These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 12819072

  • 1. Construction and characterization of a Pseudomonas aeruginosa mucoid exopolysaccharide-alginate conjugate vaccine.
    Theilacker C, Coleman FT, Mueschenborn S, Llosa N, Grout M, Pier GB.
    Infect Immun; 2003 Jul; 71(7):3875-84. PubMed ID: 12819072
    [Abstract] [Full Text] [Related]

  • 2. Human immune response to Pseudomonas aeruginosa mucoid exopolysaccharide (alginate) vaccine.
    Pier GB, DesJardin D, Grout M, Garner C, Bennett SE, Pekoe G, Fuller SA, Thornton MO, Harkonen WS, Miller HC.
    Infect Immun; 1994 Sep; 62(9):3972-9. PubMed ID: 8063415
    [Abstract] [Full Text] [Related]

  • 3. Complement deposition by antibodies to Pseudomonas aeruginosa mucoid exopolysaccharide (MEP) and by non-MEP specific opsonins.
    Pier GB, Grout M, Desjardins D.
    J Immunol; 1991 Sep 15; 147(6):1869-76. PubMed ID: 1832427
    [Abstract] [Full Text] [Related]

  • 4. Rationale for development of immunotherapies that target mucoid Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Pier GB.
    Behring Inst Mitt; 1997 Feb 15; (98):350-60. PubMed ID: 9382760
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and characterization of Pseudomonas aeruginosa alginate-tetanus toxoid conjugate.
    Kashef N, Behzadian-Nejad Q, Najar-Peerayeh S, Mousavi-Hosseini K, Moazzeni M, Djavid GE.
    J Med Microbiol; 2006 Oct 15; 55(Pt 10):1441-1446. PubMed ID: 17005795
    [Abstract] [Full Text] [Related]

  • 6. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients.
    Meluleni GJ, Grout M, Evans DJ, Pier GB.
    J Immunol; 1995 Aug 15; 155(4):2029-38. PubMed ID: 7636254
    [Abstract] [Full Text] [Related]

  • 7. Intranasal Peptide-Based FpvA-KLH Conjugate Vaccine Protects Mice From Pseudomonas aeruginosa Acute Murine Pneumonia.
    Sen-Kilic E, Blackwood CB, Boehm DT, Witt WT, Malkowski AC, Bevere JR, Wong TY, Hall JM, Bradford SD, Varney ME, Damron FH, Barbier M.
    Front Immunol; 2019 Aug 15; 10():2497. PubMed ID: 31708925
    [Abstract] [Full Text] [Related]

  • 8. Induction of opsonic antibodies to Pseudomonas aeruginosa mucoid exopolysaccharide by an anti-idiotypic monoclonal antibody.
    Schreiber JR, Pier GB, Grout M, Nixon K, Patawaran M.
    J Infect Dis; 1991 Sep 15; 164(3):507-14. PubMed ID: 1831226
    [Abstract] [Full Text] [Related]

  • 9. Immune complexes from immunized mice and infected cystic fibrosis patients mediate murine and human T cell killing of hybridomas producing protective, opsonic antibody to Pseudomonas aeruginosa.
    Pier GB, Takeda S, Grout M, Markham RB.
    J Clin Invest; 1993 Mar 15; 91(3):1079-87. PubMed ID: 8450038
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of a conjugate vaccine containing polymannuronic acid and flagellin against experimental Pseudomonas aeruginosa lung infection in mice.
    Campodónico VL, Llosa NJ, Bentancor LV, Maira-Litran T, Pier GB.
    Infect Immun; 2011 Aug 15; 79(8):3455-64. PubMed ID: 21628521
    [Abstract] [Full Text] [Related]

  • 11. Immunological evaluation of an alginate-based conjugate as a vaccine candidate against Pseudomonas aeruginosa.
    Farjah A, Owlia P, Siadat SD, Mousavi SF, Ardestani MS, Mohammadpour HK.
    APMIS; 2015 Feb 15; 123(2):175-83. PubMed ID: 25470757
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Biologic activities of antibodies to the neutral-polysaccharide component of the Pseudomonas aeruginosa lipopolysaccharide are blocked by O side chains and mucoid exopolysaccharide (alginate).
    Hatano K, Goldberg JB, Pier GB.
    Infect Immun; 1995 Jan 15; 63(1):21-6. PubMed ID: 7528730
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antibody to Pseudomonas aeruginosa mucoid exopolysaccharide and to sodium alginate in cystic fibrosis serum.
    Speert DP, Lawton D, Mutharia LM.
    Pediatr Res; 1984 May 15; 18(5):431-3. PubMed ID: 6233529
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Epitope specificity of rabbit immunoglobulin G (IgG) elicited by pneumococcal type 23F synthetic oligosaccharide- and native polysaccharide-protein conjugate vaccines: comparison with human anti-polysaccharide 23F IgG.
    Alonso de Velasco E, Verheul AF, van Steijn AM, Dekker HA, Feldman RG, Fernández IM, Kamerling JP, Vliegenthart JF, Verhoef J, Snippe H.
    Infect Immun; 1994 Mar 15; 62(3):799-808. PubMed ID: 7509318
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.